Investors should read what the company stated on their past anns.. volumes supposed to only accelerate in Dec/Jan so the 4Qquarterly numbers should not be considered a reflection of that is to come. They will show low sales in Oct and Nov and acceleration on Dec.
Now that Labcon has added the produt to their official portfolio, volumes will rise quickly but thats really gonna appear on this and next quarter.
The 4q was a warming up period to build inventories which will be delivered in the coming months, quarters and years.
the only commentary that matters (to me) is the outlook one as the performance was well telegraphed by past anns.
Bring it on 2019!
- Forums
- ASX - By Stock
- 2019 here we go
Investors should read what the company stated on their past...
Featured News
Add BCT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.737M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
BCT (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online